RNA Analysis Transcriptomics Market
Request Sample Report
RNA Analysis Transcriptomics Market Size and Growth
The RNA Analysis Transcriptomics market is witnessing substantial growth, driven by advancements in sequencing technologies and increased research funding. The market is estimated to reach approximately $6 billion by 2028. Key drivers include rising demand for personalized medicine and applications in oncology, agricultural biotechnology, and infectious disease research. Request Sample Report
Companies Covered
(Covid 19 Impact Covered)
◍ Thermo Fisher Scientific
◍ Bio-Rad Laboratories
◍ Merck KGaA
◍ Agilent Technologies
◍ Illumina
◍ QIAGEN N.V.
◍ F. Hoffmann-La Roche
◍ Danaher Corporation
◍ Fluidigm Corporation
◍ Eurofins Scientific
◍ Sequentia Biotech
◍ Acobiom
◍ GenXPro
◍ CD Genomics
◍ Promega Corporation
◍ Lexogen
◍ Cenix BioScience
The RNA Analysis Transcriptomics Market is driven by key players like Thermo Fisher Scientific, Illumina, and QIAGEN, offering advanced sequencing and analysis technologies. These companies contribute through innovative products, enhancing research capabilities in genomics. Recent revenue figures include Thermo Fisher at approximately $39 billion and Illumina at around $4.5 billion.
Request Sample Report
Market Segmentation
By Application
◍ Academic & Research Institutes
◍ Pharmaceutical & Biotechnology Companies
◍ Hospitals
By Product
◍ Microarrays
◍ Sequencing
◍ Polymerase Chain Reaction (PCR)
◍ RNA Interference
Request Sample Report
Market Growth
Request Sample Report
$ X Billion USD
